إعلان
إعلان
MIST
Milestone Pharmaceuticals Inc. Common Shares
2.04
USDبرعاية
-0.15
-6.62%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
2.05
0.00
+0.24%
تقارير أرباح MIST
النسبة الإيجابية المفاجئة
MIST تفوق 16 من 26 آخر التقديرات.
62%
التقرير التالي
بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.16
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+33.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-15.79%
Milestone Pharmaceuticals Inc. Common Shares earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, MIST reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.16 USD, resulting in a 28.27% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of -0.16 USD, with revenue projected to reach -- USD, implying an زيادة of 33.33% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Milestone Pharmaceuticals Inc. Common Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Milestone Pharmaceuticals Inc. Common Shares reported EPS of -$0.12, beating estimates by 28.27%, and revenue of $0.00, 0% as expectations.
How did the market react to Milestone Pharmaceuticals Inc. Common Shares's Q3 2025 earnings?
The stock price moved up 1.05%, changed from $1.91 before the earnings release to $1.93 the day after.
When is Milestone Pharmaceuticals Inc. Common Shares expected to report next?
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
What are the forecasts for Milestone Pharmaceuticals Inc. Common Shares's next earnings report?
Based on 7
المحللين, Milestone Pharmaceuticals Inc. Common Shares is expected to report EPS of -$0.16 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان